{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:16:18Z","timestamp":1761707778892},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T00:00:00Z","timestamp":1113350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>Dermatitis herpetiformis that is unable to be controlled using dapsone and a gluten\u2010free diet presents a therapeutic challenge. Three cases that responded well to sulfasalazine are presented. Two cases, who were unable to tolerate dapsone, had a rapid response to sulfasalazine, without apparent side\u2010effects. The third case with dapsone\u2010responsive blistering dermatoses, presumed to be dermatitis herpetiformis on the basis of serology, showed an excellent clinical response to sulfasalazine, but after 6\u2003weeks of therapy had to cease it because of side\u2010effects. Sulfasalazine is metabolized variably to sulfapyridine, a sulphonamide known to be an effective therapy for dermatitis herpetiformis but no longer available. Sulfasalazine should be considered as a management option for dermatitis herpetiformis.<\/jats:p>","DOI":"10.1111\/j.1440-0960.2005.00152.x","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T16:53:55Z","timestamp":1113411235000},"page":"101-103","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Sulfasalazine and dermatitis herpetiformis"],"prefix":"10.1111","volume":"46","author":[{"given":"Elizabeth","family":"Willsteed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li Chuen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,4,13]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81054-7"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.114.10.1553b"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1991.tb01236.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510040-00001"},{"key":"e_1_2_6_6_2","first-page":"230","volume-title":"Comprehensive Dermatologic Drug Therapy.","author":"Hall RP","year":"2001"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110474"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233335"},{"key":"e_1_2_6_9_2","first-page":"134","article-title":"Dermatitis herpetiformis treated with sulfapyridine","volume":"41","author":"Costello M","year":"1940","journal-title":"Arch. Dermatol. Syphil."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000256874"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70092-X"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119671"},{"key":"e_1_2_6_13_2","first-page":"1","volume-title":"MIMS Annual","author":"Carroll PR","year":"2003"}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-0960.2005.00152.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-0960.2005.00152.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:14:07Z","timestamp":1697408047000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-0960.2005.00152.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,13]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1111\/j.1440-0960.2005.00152.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-0960.2005.00152.x","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,13]]},"assertion":[{"value":"2005-04-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}